19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML).

Int J Mol Sci · 2022 · PMC9740165 · PMID 36498916

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)

However, in MOLM-14 cells, shPSMD3 showed a trend for reduced NF-κB transcriptional activity, which was not further reduced by quizartinib therapy ( Figure 4 B; p = 0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.